RBC Capital Maintains Sector Perform on Elevance Health, Lowers Price Target to $424
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice TargetHot
RBC Capital analyst Ben Hendrix maintains Elevance Health (NYSE:ELV) with a Sector Perform and lowers the price target from $439 to $424.
RBC Capital analyst Ben Hendrix maintains Elevance Health (NYSE:ELV) with a Sector Perform and lowers the price target from $439 to $424.